Takeda Pharmaceutical Company Limited (TAK) Reports Q2 EPS of JPY151.00
Takeda Pharmaceutical Company Limited (NYSE: TAK) reported Q2 EPS of JPY151.00. Revenue for the quarter came in at JPY1106.7 billion.
For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.
